Skip to main content

Table 3 Effects of Bersama engleriana on blood glucose in nicotinamide/streptozotocin-induced type 2 diabetic rats

From: Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats

Groups Fasting blood glucose level (mg/dl)
   Week of treatment
  At the time of grouping Week 0 Week 1 Week 2 Week 4
Control 97.80 ± 02.97 69.00 ± 07.40a 75.8 ± 09.05a 81.00 ± 04.25a 62.00 ± 03.45a
Untreated diabetic 97.40 ± 04.54 270.80 ± 81.14a*** 244.40 ± 69.28a*** 202.60 ± 55.54a* 203.00 ± 46.62a**
Diabetic + Glibenclamide (0.25 mg/kg) 86.40 ± 06.53 227.80 ± 83.62a** 146.40 ± 51.05ad 98.20 ± 09.28bd 94.20 ± 11.20bd
Diabetic + Aqueous extract (300 mg/kg) 95.40 ± 05.08 156.60 ± 20.76#a 121.80 ± 06.80#a 109.60 ± 07.15a 96.60 ± 02.67a
Diabetic + Aqueous extract (600 mg/kg) 91.00 ± 06.47 303.80 ± 41.86a*** 183.60 ± 33.96bd 119.00 ± 04.63cd 98.00 ± 07.52c
Diabetic + Methanolic extract (300 mg/kg) 90.20 ± 04.18 181.80 ± 48.41a* 114.00 ± 15.71#a 86.60 ± 07.35#a 83.60 ± 08.18#a
Diabetic + Methanolic extract (600 mg/kg) 90.20 ± 03.38 454.00 ± 10.93a*** ### 288.40 ± 45.75b*** 167.60 ± 42.28c 89.40 ± 06.23#c
  1. Values are means ± SEM; number of animals per group = 6.
  2. On the same line, values assigned with the same letter are not significantly different.
  3. Within a column, *: p<0.05; **: p <0.01; *** p <0.001: significantly different compared to control.
  4. #: p <0.05; ###: p <0.001: significantly different compared to untreated diabetic.